Briefing

Industry news

Industry briefing

NEWS

FDA grants priority review for Biogen’s tofersen to treat ALS

The US FDA has granted priority review for Biogen’s New Drug Application (NDA) for its gene therapy tofersen to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS)

news

Amgen to acquire biopharma firm ChemoCentryx for $3.7bn

Amgen has signed a definitive agreement to acquire ChemoCentryx for $52 for each share in cash or a total enterprise cost of nearly $3.7bn

Briefing

BeiGene reports Phase III tislelizumab data in hepatocellular cancer

BeiGene reported positive data from the Phase III RATIONALE 301 trial of tislelizumab as a first-line therapy for adult unresectable HCC patients

Industry news

Industry briefing

08/19/2022 18:28:48
  • Home | Technology transformation
  • In this issue
  • Contents
  • SHL Medical Company Insight
  • SHL Medical
  • Datwyler Company Insight
  • Datwyler
  • CSafe Global
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Mimotopes Company Insight
  • Mimotopes
  • Comment
  • Tapping into pharma’s growing opportunities in digital health
  • Covid-19 Omicron boosters will reinvigorate injectables manufacturing
  • Implementation of electronic health records will improve the quality of care
  • Despite benefits, long-acting injectables remain underutilised for schizophrenia
  • FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
  • UK health data collaboration paves the way to study Long Covid symptoms
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • In Depth
  • A makeover for NICE: a new look for HTAs in the UK
  • No drugs for prions: investigating new approaches to alleviate therapeutic scarc
  • Getting smart with digital pills
  • Do generics producers have what it takes to tackle complex and specialty drugs?
  • Decentralised paediatric clinical trials trending up but study execution critica
  • CMO Moves: Regulatory catalysts for drug manufacturing—August
  • Biolife Solutions
  • In Data
  • Healthtech deals decreased significantly in the pharma industry in H1 2022
  • North America is seeing a hiring boom in pharmaceutical industry machine learnin
  • Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
  • Digital media hiring levels in the pharmaceutical industry rose in June 2022
  • Events
  • Next issue